News

Published on 23 Oct 2023 on Benzinga

...Alphabet (NASDAQ:GOOGL), Logitech International (NASDAQ:LOGI), Archer-Daniels Midland (NYSE:ADM),...


Article preview image

After the first week of earnings, analysts have tempered their expectations for profit growth, anticipating a continuation of the profit-declining trend.

The Week That Was: The blended year-over-year earnings of S&P 500 companies are expected to decrease by 0.4%, marking the fourth consecutive decline, according to Factset’s weekly earnings insights report. The decline in earnings is largely due to downward revisions in earnings per share (EPS) estimates for Pfizer, Inc. PFE and Eli Lilly & Co. LLY.

PAR.STMPA price evolution
NASDAQ.SKYW price evolution
NYSE.SPOT price evolution
NASDAQ.CHTR price evolution
NYSE.CL price evolution
NASDAQ.HAS price evolution
NYSE.AIU price evolution
NYSE.BSX price evolution
NASDAQ.LOGI price evolution
NYSE.NVS price evolution
SIX.LOGN price evolution
NYSE.PKG price evolution
NYSE.COF price evolution
NASDAQ.BJRI price evolution
NYSE.VFC price evolution
NYSE.STM price evolution
NYSE.BYD price evolution
NASDAQ.XRX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Exploring Three Swiss Dividend Stocks With Yields Up To 3.9%

The Switzerland market demonstrated robust performance recently, concluding a notably strong sess...

Simply Wall St. via Yahoo Finance 3 Jun 2024

Incyte (INCY) Up 7.5% Since Last Earnings Report: Can It Continue?

A month has gone by since the last earnings report for Incyte (INCY). Shares have added about 7.5...

Zacks via Yahoo Finance 30 May 2024

Goldman Sachs initiates cover on six European pharma stocks By Investing.com

Goldman Sachs initiates cover on six European pharma stocks

Investing.com 30 May 2024

Exploring Three Japanese Growth Companies With High Insider Ownership On The Tokyo Stock Exchange

Amid a backdrop of fluctuating global markets, with Japan's Nikkei 225 experiencing slight declin...

Simply Wall St. via Yahoo Finance 30 May 2024

Novartis stock rated 'Buy' by Goldman Sachs, highlighting robust innovation By Investing.com

On Thursday, Goldman Sachs (NYSE:GS) initiated coverage on Novartis AG (SIX:NOVN) stock, listed a...

Investing.com 30 May 2024

Goldman Sachs Says Buy European Pharma Stocks Touting Innovation

(Bloomberg) -- European drugmakers that are focused on building portfolios of new medicines have ...

Bloomberg via Yahoo Finance 30 May 2024

Exploring Swiss Dividend Stocks In May 2024

Amidst a cautious atmosphere driven by inflation concerns and interest rate outlooks, the Swiss m...

Simply Wall St. via Yahoo Finance 29 May 2024

Calliditas Therapeutics’ stock surges after $1.1 billion takeover bid

jumped more than 70% premarket on Tuesday after a nearly $1.1 billion takeover bid from Japanese...

Market Watch 28 May 2024

Is Vanguard International Dividend Appreciation ETF (VIGI) a Strong ETF Right Now?

Designed to provide broad exposure to the World ETFs category of the market, the Vanguard Interna...

Zacks via Yahoo Finance 27 May 2024

Exploring Three Swiss Dividend Stocks With Yields Up To 4.6%

The Switzerland market recently displayed a downturn, influenced by ongoing concerns about U.S. i...

Simply Wall St. via Yahoo Finance 26 May 2024